论文部分内容阅读
美国在过去10到15年中,生物技术虽然发展迅猛,但对生物医学研究的资助却一直在逐渐下降。对生物医学研究的资助无论是从给予的现金金额,或是其在卫生事业总经费中所占的比率来说都是如此。在1970年,约有3.9％的卫生事业费用于生物医学的研究及其发展,而在1982年则下降到2.9％。即在美国占3,170亿美元全年卫生事业总经费预算中仅有92美亿元用于生物医学研究及其发展。按任何事业的标准来说,用于研究和发展的投资的经费实在太
In the past 10 to 15 years in the United States, biotechnology has developed rapidly, but funding for biomedical research has been steadily declining. The funding for biomedical research is either from the amount of cash given or its share of the total funding for health services. In 1970, about 3.9% of health expenditures were spent on biomedical research and development, and in 1982 they dropped to 2.9%. That is, in the United States, which accounted for 317 billion U.S. dollars, the total budget for health services for the entire year was only 92 million U.S. dollars for biomedical research and development. According to the standards of any business, the funds for investment in research and development are too large.